Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 10/20 | 0.56 |
| ▸ | PPARD | Q03181 | 10/20 | 0.56 |
| ▸ | PPARA | Q07869 | 9/20 | 0.56 |
| ▸ | LTB4R | Q15722 | 4/20 | 0.45 |
| ▸ | LTB4R2 | Q9NPC1 | 4/20 | 0.45 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5209680 | 0.89 | PPARG (0.57) | PPARGPPARDPPARALTB4RLTB4R2 | |
| SCHEMBL5208530 | 0.82 | PPARD (0.49) | PPARGPPARDPPARALTB4RLTB4R2 | |
| SCHEMBL5208981 | 0.79 | PPARG (0.51) | PPARGPPARDPPARALTB4RLTB4R2 | |
| SCHEMBL6559159 | 0.74 | PPARA (0.63) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7459824 | 0.73 | PDE5A (0.35) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7531877 | 0.73 | PPARG (0.38) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7523011 | 0.73 | PPARG (0.38) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7466873 | 0.73 | PPARG (0.45) | PPARGPPARDPPARA | |
| SCHEMBL5211380 | 0.72 | PPARG (0.62) | PPARGPPARDPPARA | |
| SCHEMBL5204448 | 0.72 | PPARG (0.40) | PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1040102-B1 | ARYLTHIAZOLIDINEDIONE DERIVATIVES | MERCK & CO INC (US) | 2007-01-24 | — | — | EP | disclosed |
| US-6399640-B1 | ANTIDIABETIC AGENTS; ANTICHOLESTEROL AGENTS | MERCK & CO., INC. | 2002-06-04 | — | — | US | disclosed |
| US-6200998-B1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONISTS; ANTICHOLESTEROL, ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. | 2001-03-13 | — | — | US | disclosed |
| US-6008237-A | POTENT AGONISTS OF PEROXIDSOME PROLIFERATOR ACTIVATED RECEPTOR; FOR CONTROLLING OR PREVENTING OF DIABETES, HYPERGLYCEMIA, HYPERLIPIDEMIA, HYPERCHOLESTEROLEMIA, ATHEROSCLEROSIS, OBESITY, VASCULAR RESTENOSIS | MERCK & CO., INC. (US) | 1999-12-28 | — | — | US | disclosed |